{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:47:38Z","timestamp":1775080058674,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012569","name":"University of Toledo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.annepidem.2026.110077","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:04:44Z","timestamp":1773335084000},"page":"110077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["mRNA-based COVID-19 vaccination and risk of autoimmune diseases in the pediatric population"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5884-0879","authenticated-orcid":false,"given":"Mounika","family":"Polavarapu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Mukundan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Bova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2026.110077_bib1","unstructured":"Autoimmune Diseases. Boston Children\u2019s Hospital. Accessed May 22, 2025. \u3008https:\/\/www.childrenshospital.org\/conditions\/autoimmune-diseases\u3009."},{"key":"10.1016\/j.annepidem.2026.110077_bib2","unstructured":"Autoimmune diseases. National Institute of Environmental Health Sciences. Autoimmune diseases. Accessed May 22, 2025. \u3008https:\/\/www.niehs.nih.gov\/health\/topics\/conditions\/autoimmune\u3009."},{"issue":"8","key":"10.1016\/j.annepidem.2026.110077_bib3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00296-023-05346-x","article-title":"Systemic lupus erythematosus: latest insight into etiopathogenesis","volume":"43","author":"Akhil","year":"2023","journal-title":"Rheuma Int"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110077_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12091","article-title":"Virus infection, antiviral immunity, and autoimmunity","volume":"255","author":"Getts","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.annepidem.2026.110077_bib5","series-title":"Advances in Immunology","first-page":"25","article-title":"Genetic susceptibility to autoimmunity\u2014current status and challenges","year":"2022"},{"key":"10.1016\/j.annepidem.2026.110077_bib6","first-page":"1","article-title":"Environmental triggers and autoimmunity","volume":"2014","author":"Vojdani","year":"2014","journal-title":"Autoimmune Dis"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110077_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/cid\/ciz135","article-title":"Principal controversies in vaccine safety in the United States","volume":"69","author":"DeStefano","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.annepidem.2026.110077_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/vaccines9080815","article-title":"Vaccinations and autoimmune diseases","volume":"9","author":"Olivieri","year":"2021","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110077_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13167-017-0101-y","article-title":"Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?","volume":"8","author":"Vadal\u00e0","year":"2017","journal-title":"EPMA J"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110077_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain-Barr\u00e9 syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis Publ Infect Dis Soc Am"},{"issue":"14","key":"10.1016\/j.annepidem.2026.110077_bib11","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJMoa032665","article-title":"Childhood vaccination and type 1 diabetes","volume":"350","author":"Hviid","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110077_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archneur.60.4.504","article-title":"Vaccinations and risk of central nervous system demyelinating diseases in adults","volume":"60","author":"DeStefano","year":"2003","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110077_bib13","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.6.e112","article-title":"Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus","volume":"108","author":"DeStefano","year":"2001","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.annepidem.2026.110077_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2026.110077_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102898","article-title":"Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review","volume":"132","author":"Rodr\u00edguez","year":"2022","journal-title":"J Autoimmun"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110077_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103340","article-title":"Insights into new-onset autoimmune diseases after COVID-19 vaccination","volume":"22","author":"Guo","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110077_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"issue":"16","key":"10.1016\/j.annepidem.2026.110077_bib18","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.3390\/jcm13164617","article-title":"Could vaccination against COVID-19 trigger immune-mediated inflammatory diseases?","volume":"13","author":"Liakou","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.annepidem.2026.110077_bib19","article-title":"Outcomes in children with rheumatic diseases following COVID-19 vaccination and infection: data from a large two-center cohort study in Thailand","volume":"11","author":"Lerkvaleekul","year":"2023","journal-title":"Front Pedia"},{"key":"10.1016\/j.annepidem.2026.110077_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110723","article-title":"Association between Covid-19 vaccination and incidence of type 1 diabetes in China: evidence from 14.14 million registered residents between 2007 and 2021","volume":"201","author":"Liu","year":"2023","journal-title":"Diabetes Res Clin Pr"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110077_bib21","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12020-023-03471-y","article-title":"SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus","volume":"82","author":"Karavanaki","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.annepidem.2026.110077_bib22","unstructured":"TriNetX, LLC. \u3008https:\/\/live.trinetx.com\/\u3009."},{"issue":"8","key":"10.1016\/j.annepidem.2026.110077_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.annepidem.2026.110077_bib24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.annepidem.2026.110077_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1024924","article-title":"Duration of immunity to SARS-CoV-2 in children after natural infection or vaccination in the omicron and pre-omicron era: a systematic review of clinical and immunological studies","volume":"13","author":"Buonsenso","year":"2023","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110077_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jamapediatrics.2022.3072","article-title":"Analysis of neutralizing antibody levels in children and adolescents up to 16 months after SARS-CoV-2 infection","volume":"176","author":"Yung","year":"2022","journal-title":"JAMA Pedia"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110077_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/14760584.2024.2331065","article-title":"The durability of vaccine-induced protection: an overview","volume":"23","author":"Vashishtha","year":"2024","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.annepidem.2026.110077_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front Pharm"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110077_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.annepidem.2026.110077_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.annepidem.2026.110077_bib31","unstructured":"doi:10.17226\/27746. National Academies of Sciences, Engineering, and Medicine. Immunologic Response to COVID-19 Vaccines National Academies of Sciences, Engineering, and Medicine. 2024. Evidence Review of the Adverse Effects of COVID-19 Vaccination and Intramuscular Vaccine Administration. Washington, DC: The National Academies Press. https:\/\/doi.org\/10.17226\/27746. In: Evidence Review of the Adverse Effects of COVID-19 Vaccination and Intramuscular Vaccine Administration. National Academies Press; 2024. ."},{"issue":"11","key":"10.1016\/j.annepidem.2026.110077_bib32","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.annepidem.2026.110077_bib33","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine Into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Karik\u00f3","year":"2008","journal-title":"Mol Ther"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110077_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Karik\u00f3","year":"2005","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.annepidem.2026.110077_bib35","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1093\/nar\/gkq347","article-title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation","volume":"38","author":"Anderson","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"10.1016\/j.annepidem.2026.110077_bib36","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1093\/nar\/gkr586","article-title":"Nucleoside modifications in RNA limit activation of 2\u2019-5\u2019-oligoadenylate synthetase and increase resistance to cleavage by RNase L","volume":"39","author":"Anderson","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.annepidem.2026.110077_bib37","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.immuni.2022.08.008","article-title":"SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic","volume":"55","author":"Bertoletti","year":"2022","journal-title":"Immunity"},{"issue":"66","key":"10.1016\/j.annepidem.2026.110077_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl5344","article-title":"BNT162b2 vaccination induces durable SARS-CoV-2\u2013specific T cells with a stem cell memory phenotype","volume":"6","author":"Guerrera","year":"2021","journal-title":"Sci Immunol"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110077_bib39","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/all.14364","article-title":"Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19","volume":"75","author":"Azkur","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.annepidem.2026.110077_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102154","article-title":"Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study","volume":"63","author":"Peng","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110077_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/antib11020025","article-title":"Cellular, Antibody and cytokine pathways in children with acute SARS-CoV-2 infection and MIS-C\u2014can we match the puzzle?","volume":"11","author":"Lazova","year":"2022","journal-title":"Antibodies"},{"key":"10.1016\/j.annepidem.2026.110077_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.941009","article-title":"Multisystem inflammatory syndrome in children and long COVID: the SARS-CoV-2 viral superantigen hypothesis","volume":"13","author":"Noval Rivas","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.annepidem.2026.110077_bib43","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/jamadermatol.2024.4233","article-title":"Long-term risk of autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"160","author":"Heo","year":"2024","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.annepidem.2026.110077_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101783","article-title":"Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study","volume":"56","author":"Chang","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110077_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12916-023-03049-5","article-title":"Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care","volume":"21","author":"Syed","year":"2023","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.annepidem.2026.110077_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36120","article-title":"Autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"6","author":"Lim","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.annepidem.2026.110077_bib47","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2666-5247(21)00275-5","article-title":"T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study","volume":"3","author":"Angyal","year":"2022","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.annepidem.2026.110077_bib48","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/cid\/ciac637","article-title":"BNT162b2 mRNA vaccination against coronavirus disease 2019 is associated with a decreased likelihood of multisystem inflammatory syndrome in Children Aged 5\u201318 years\u2014United States, July 2021 \u2013 April 2022","volume":"76","author":"Zambrano","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annepidem.2026.110077_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126499","article-title":"Multisystem inflammatory syndrome in children (MIS-C) cases by vaccination status in California","volume":"43","author":"Le Marchand","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.annepidem.2026.110077_bib50","article-title":"ERIC notebook series: information bias. 2nd ed. North Carolina institute for public health","author":"Alexander","year":"2025","journal-title":"Univ North Carol Gillings Sch Glob Public Health"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110077_bib51","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/1471-0528.14960","article-title":"Hidden biases in observational epidemiology: the case of unmeasured confounding","volume":"125","author":"Ananth","year":"2018","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.annepidem.2026.110077_bib52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/rheumatology\/kex005","article-title":"Family history of systemic lupus erythematosus and risk of autoimmune disease: Nationwide cohort study in Denmark 1977-2013","volume":"56","author":"Ulff-M\u00f8ller","year":"2017","journal-title":"Rheuma Oxf Engl"},{"key":"10.1016\/j.annepidem.2026.110077_bib53","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaf251","article-title":"Familial risk of hashimoto\u2019s thyroiditis in a large genealogical database","author":"Bujnis","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.annepidem.2026.110077_bib54","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2147\/CLEP.S172207","article-title":"Familial aggregation and heritability of type 1 diabetes mellitus and coaggregation of chronic diseases in affected families","volume":"10","author":"Kuo","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.annepidem.2026.110077_bib55","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39127","article-title":"Familial risk of Sj\u00f6gren\u2019s syndrome and Co-aggregation of autoimmune diseases in affected families: a nationwide population study","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheuma"},{"issue":"2","key":"10.1016\/j.annepidem.2026.110077_bib56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00415-018-9163-6","article-title":"Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study","volume":"266","author":"Song","year":"2019","journal-title":"J Neurol"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104727972600075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104727972600075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:44:58Z","timestamp":1775072698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104727972600075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"alternative-id":["S104727972600075X"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110077","relation":{},"ISSN":["1047-2797"],"issn-type":[{"value":"1047-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mRNA-based COVID-19 vaccination and risk of autoimmune diseases in the pediatric population","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2026.110077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110077"}}